(Q42488243)

English

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

scientific article published on October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Maria F Gangale

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Luca Miele

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Antonio Lanzone

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Francesca Sagnella

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Daniela Martinez

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Anna Tropea

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Francesca Moro

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Andrea Morciano

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Andrea Ciardulli

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Carola Palla

10

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Maurizio Pompili

11

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Consuelo Cefalo

12

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Antonio Grieco

13

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Rosanna Apa

14

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

520-527

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Review: The role of insulin resistance in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Abnormal aminotransferase activity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Ultrasonic elastography in clinical quantitative assessment of fatty liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

The metabolic syndrome in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Significant correlations between severe fatty liver and risk factors for metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Sex hormone-binding globulin and female reproductive function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04093.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2011.04093.X

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42488243&oldid=1959532268"